Article
Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?
European journal of clinical pharmacology - 1 Oct 2015
Goktaş Mustafa Tugrul, Hatta Fazleen, Karaca Ozgur, Kalkisim Said, Kilic Levent, Akdogan Ali, Babaoglu Melih O, Bozkurt Atilla, Helldén Anders, Bertilsson Leif, Yasar Umit
Abstract excerpt
BACKGROUND: We previously reported on a Swedish patient with Behçet's disease (BD) who was an ultra-rapid metaboliser of drugs catalysed by CYP2C9. Was this extreme metabolism caused by the disease? AIM: This study aims to compare the genotype/phenotype of CYP2C9 in patients with BD and healthy subjects. As the occurrence of BD is high in Turkey, all subjects were recruited from this country. METHODS: Genotyping...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
